Huang Jane

CIK 00016839133 companiesWILMINGTON, DE

SEC Profile

Transactions

Companies

Filings

CIK

0001683913

Recent Transactions

50 trades

Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2025-10-04+9,375→ 90,272 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2025-10-04$1.47/sh−3,355→ 86,917 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2025-10-04−9,375→ 18,750 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2025-07-04$0.79/sh−3,355→ 80,897 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2025-07-04−9,375→ 28,125 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2025-07-04+9,375→ 84,252 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2025-06-12+24,000→ 24,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2025-04-04−9,375→ 37,500 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2025-04-04+9,375→ 78,232 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2025-04-04$0.68/sh−3,355→ 74,877 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2025-02-04+200,000→ 200,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2025-01-04+9,375→ 46,875 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2025-01-04$1.39/sh−3,859→ 68,857 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2025-01-04+9,375→ 72,716 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2024-10-04$2.00/sh−3,349→ 63,341 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2024-10-04−9,375→ 56,250 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2024-10-04+9,375→ 66,690 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2024-07-04−9,375→ 65,625 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2024-07-04$3.60/sh−3,347→ 57,315 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2024-07-04+9,375→ 60,662 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2024-06-07+10,000→ 10,000 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2024-04-04$4.74/sh−3,347→ 51,287 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2024-04-04−9,375→ 75,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2024-04-04+9,375→ 54,634 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2024-03-01+175,000→ 175,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2024-01-04+9,375→ 49,103 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2024-01-04−9,375→ 84,375 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2024-01-04$3.77/sh−3,844→ 45,259 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2023-10-04+9,375→ 93,750 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2023-10-04+9,375→ 39,728 total
Tax Payment
Prelude Therapeutics Inc$PRLD
Common Stock
2023-07-04$4.65/sh−3,242→ 30,353 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2023-07-04−9,375→ 103,125 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2023-07-04+9,375→ 33,595 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2023-06-07+10,000→ 10,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2023-04-06$6.12/sh−13,280→ 24,220 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2023-04-04−37,500→ 112,500 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2023-04-04+37,500→ 37,500 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2023-02-07+150,000→ 150,000 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2022-06-08+10,000→ 10,000 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2022-05-02+460,000→ 460,000 total
Award
Prelude Therapeutics Inc$PRLD
Restricted Stock Unit
2022-05-02+150,000→ 150,000 total
Exercise/Conversion
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-14$119.96/sh+1,500→ 1,500 total
Exercise/Conversion
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2021-12-14−19,500→ 211,276 total
Sale
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-14$284.52/sh−100→ 0 total
Sale
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-14$278.79/sh−100→ 300 total
Sale
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-14$281.63/sh−200→ 100 total
Sale
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-14$278.21/sh−500→ 400 total
Sale
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-14$274.54/sh−300→ 1,200 total
Sale
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-14$276.95/sh−300→ 900 total
Sale
BeOne Medicines Ltd.$ONC
American Depositary Shares
2021-12-01$357.32/sh−530→ 519 total

Companies

Recent Filings

Address

C/O PRELUDE THERAPEUTICS INCORPORATED 175 INNOVATION BOULEVARD

WILMINGTON, DE, 19805

View on SEC.gov